Literature DB >> 3899686

Studies of fibronectin synthesized by cultured chick hepatocytes.

D L Amrani, M J Falk, M W Mosesson.   

Abstract

We have adapted a chick embryo liver cell system for studying the synthesis of proteins secreted by hepatocytes. In primary liver cell cultures maintained for several days in arginine-deficient medium containing ornithine (0.7 mM) and carbamyl phosphate (1 mM), only hepatocytes demonstrated normal morphological and biosynthetic characteristics, indicating that they possessed a functional ornithine cycle as a source of arginine production. Non-parenchymal liver cells, such as fibroblasts, which lack the ornithine cycle were excluded. Hepatocytes in arginine-deficient or arginine-containing medium synthesized fibronectin (Fn) over several days at a constant rate of 3 micrograms +/- 1 microgram/mg cell protein per day, with fibronectin representing approximately 3% of the total secreted hepatocyte proteins during any culture period after the first 24 h. Pulse-chase experiments indicated that Fn synthesis and secretion was relatively rapid (t1/2 = 45 min) and represented approximately 95% of the intracellularly labelled Fn. This Fn is secreted predominantly as a 450 kD dimer with a subunit size that is indistinguishable from the plasma form as assessed by one-dimensional electrophoretic analysis. Continuous exposure of hepatocytes to insulin caused a moderate decrease (26%) in Fn synthesis, whereas there was no effect of short-term exposure. In contrast, dexamethasone stimulated Fn production 2-3-fold, consistent with its known ability to stimulate hepatocyte production of acute phase proteins. Under these conditions, electrophoretic analyses showed that an increased quantity of intact hepatocyte Fn was produced having the same molecular size of plasma Fn.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899686     DOI: 10.1016/0014-4827(85)90246-0

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Expression of fibronectin and laminin by different types of mouse glial cells cultured in a serum-free medium.

Authors:  T Yoshida; M Takeuchi
Journal:  Cytotechnology       Date:  1991-11       Impact factor: 2.058

2.  Effect of hepatocyte-stimulating factor and glucocorticoids on plasma fibronectin levels.

Authors:  D L Amrani; D Mauzy-Melitz; M W Mosesson
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

3.  Biological markers as indicators of exposure and pneumoconiotic risk: prospective study.

Authors:  J M Porcher; C Lafuma; R el Nabout; M P Jacob; P Sébastien; P A Borm; S Honnons; G Auburtin
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

4.  Circulating Exosomal miR-144-3p from Crohn's Disease Patients Inhibits Human Umbilical Vein Endothelial Cell Function by Targeting FN1.

Authors:  Peng Qu; Xiaoran Xie; Jingshu Chi; Xiaoming Liu; Peng Liu; Ju Luo; Huan Li; Sha Cheng; Xiujuan Xia; Xiong Chen; Canxia Xu
Journal:  Dis Markers       Date:  2022-06-02       Impact factor: 3.464

Review 5.  Using proteomics to uncover extracellular matrix interactions during cardiac remodeling.

Authors:  Nicolle L Patterson; Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Yaojun Li; Thomas G Andrews; Gregory J Aune; Richard A Lange; Merry L Lindsey
Journal:  Proteomics Clin Appl       Date:  2013-07-08       Impact factor: 3.494

6.  Adrenocorticotrophic hormone fails to alter plasma fibrinogen and fibronectin values in calves but does so in rabbits.

Authors:  P A Gentry; R M Liptrap; R R Tremblay; L Lichen; M L Ross
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

7.  Alternative splicing of chicken fibronectin in embryos and in normal and transformed cells.

Authors:  P A Norton; R O Hynes
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

8.  Stimulation of rat hepatocyte fibronectin production by monocyte-conditioned medium is due to interleukin 6.

Authors:  M E Lanser; G E Brown
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.